Search results for "gynecology"

showing 10 items of 3254 documents

The "neurologic hypothesis": A new concept in the pathogenesis of the endometriosis?

2005

To cartograph the retroperitoneal infiltration of deep-infiltrating endometriosis of the rectovaginal space, we report on 467 patients who underwent laparoscopic/vaginal surgery for deep-infiltrating adenomyosis of the rectovaginal space. Exact localisation of the locoregional extension and of secondary infiltrating localisation where noted. The cervix and the rectovaginal ligament were mostly involved, while isolated lesions of the rectovaginal space were very rare. Comparisons of the most involved sites show an absolute correlation with the anatomical repartition of the pelvic sympathetic nervous system. We postulate a new "neurologic theory" which could be one more explanation for the de…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryEndometriosisEndometriosisLaparoscopic-vaginal surgeryObstetrics and GynecologyInterventional radiologymedicine.diseaseEndometriosis; Laparoscopic-vaginal surgery; Sympathetic nerve systemSurgerySympathetic nerve systemmedicine.anatomical_structurePeritoneumObstetrics and gynaecologySurgical oncologyLigamentMedicineSurgeryAdenomyosisRadiologyEndometriosibusinessCervix
researchProduct

Endometrial cancer: Robotic versus Laparoscopic treatment. Preliminary report

2015

Laparoscopic approach is today the standard treatment for benign and malignant gynecological pathologies. To traditional laparoscopic surgery in the last 10 years we can add the possibility to use a robotic platform. The adoption of this system allows undoubted advantages as the three-dimensional vision, the absence of the physiological tremor with enhanced ergonomics and possibility of using articulable tools. In this study we analyzed the results of 18 patients with endometrial cancer (Stage I) treated with robotic approach. The results were compared with a selected sample of 26 patients, with the same characteristics, treated with traditional laparoscopic approach in the same period by t…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryGeneral surgeryEndometrial cancerChirurgia robotica; Ginecologia oncologica; Hysterectomy. Isterectomia robotica; Laparoscopia; Laparoscopy; Robotic hysterectomy; Robotic surgery; Obstetrics and GynecologyChirurgia roboticaObstetrics and GynecologyGinecologia oncologicaRobotic surgerymedicine.diseaseRobotic hysterectomyLaparoscopiaHysterectomy. Isterectomia roboticaObstetrics and gynaecologyPreliminary reportmedicineRobotic surgeryLaparoscopyRobotic hysterectomyLaparoscopybusinessLaparoscopic treatment
researchProduct

Peut-on proposer un prélèvement du ganglion sentinelle en cas de chimiothérapie néoadjuvante dans les cancers du sein et à quel moment ?

2016

The main goal of preoperative chemotherapy is to reduce the size of the tumor and allow conservative treatment. Neoadjuvant treatment can affect axillary status with a downstaging in one third of the cases. For these patients, the benefit of axillary node dissection is questioned and the sentinel node biopsy (SLNB) seems to be a relevant option. However, the timing of performing SLNB is still debated especially for clinical negative patients with negative axillary ultrasound before preoperative chemotherapy. For axillary positive nodes proved by biopsy/cytology before preoperative chemotherapy, SLNB can be an option if there is a good clinical and radiological response.

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrySentinel lymph nodeObstetrics and GynecologyAxillary Node DissectionGeneral Medicine030230 surgerySentinel nodemedicine.disease3. Good health03 medical and health sciences0302 clinical medicineBreast cancerReproductive MedicineNeoadjuvant treatment030220 oncology & carcinogenesisCytologyBiopsyMedicinePreoperative chemotherapyRadiologybusinessGynécologie Obstétrique & Fertilité
researchProduct

Is x-ray compulsory in pubic symphysis diastasis diagnosis?

2013

SirWe read with great interest your case of postpartum symphy-sis pubis separation (1). We would like to present a case ofpubic symphysis diastasis that we diagnosed with a differentapproach.A 36-year-old gravida 1 para 0 at 39.6 weeks’ gestation wasadmitted with the onset of spontaneous contraction. After threehours and 18 min she delivered a 3170 g baby without compli-cations.Three hours after delivery, she complained of severe pain inthe symphysis pubic region. On examination, there was localtenderness in that region. We performed an ultrasound exami-nation, which revealed a 15.2-mm gap in the region of the sym-physis pubis (Figure 1), diagnosed as pubic symphysis diastasis.She was given…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrySymphysisPubic Symphysis Diastasismedicine.medical_treatmentUltrasoundObstetrics and GynecologyPubic symphysisGeneral Medicinemedicine.diseaseBed restPalpationSurgerymedicine.anatomical_structureDiastasisMedicineOutpatient clinicpubic symphysis diastasisbusiness
researchProduct

Tips and tricks in office hysteroscopy

2015

Abstract Office hysteroscopy is a minimally invasive procedure that has been shown to be highly accurate in diagnosing abnormalities of the endometrial cavity and the endocervical canal. It allows the direct visualizing of uterine pathology without the need for general anesthesia and the use of an operating room, generating cost savings and greater compliance among patients. The advent of small-diameter hysteroscopes, the use of saline solution as a distension media, as well as the vaginoscopic technique have widely contributed to the diffusion of this technique worldwide, and currently it can be considered the gold standard for the examination of the uterine cavity. The improved technology…

medicine.medical_specialtymedicine.diagnostic_testtips and tricksEndocervical canalbusiness.industryGeneral surgeryGold standardObstetrics and Gynecologyoperative proceduresSettore MED/40 - Ginecologia E Ostetricialcsh:Gynecology and obstetricsEndometrial cavityCost savingsSurgeryoperative proceduremedicine.anatomical_structureHysteroscopymedicineHysteroscopesUterine cavitybusinesslcsh:RG1-991Minimally invasive proceduresoffice hysteroscopyGynecology and Minimally Invasive Therapy
researchProduct

Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer

2007

Abstract Background. Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) contribute to the invasiveness of many carcinomas. Here, we studied a possible association between cytosolic uPA and PA-1 concentrations in tumor tissue with prognosis in patients with endometrial cancer. Methods. Cytosolic concentrations of uPA and PAI-1 were determined in 69 primary endothelial adenocarcinomas using an enzyme-linked immunoassay (ELISA). A possible influence of uPA and PAI-1 was studied by multivariate Cox regression adjusting for the established clinical prognostic factors FIGO-stage, grading, depth of invasion, diabetes mellitus and age. Results. Both uPA ( …

medicine.medical_specialtymedicine.drug_classAdenocarcinomaDisease-Free SurvivalMetastasisPredictive Value of TestsGermanyInternal medicineDiabetes mellitusPlasminogen Activator Inhibitor 1Progesterone receptorBiomarkers TumormedicineHumansNeoplasm StagingUrokinasebusiness.industryProportional hazards modelEndometrial cancerObstetrics and GynecologyMiddle AgedPrognosismedicine.diseaseSurvival AnalysisUrokinase-Type Plasminogen ActivatorEndometrial NeoplasmsEndocrinologyOncologyEstrogenFemalebusinessPlasminogen activatormedicine.drugGynecologic Oncology
researchProduct

The early response of the postmenopausal endometrium to tamoxifen: expression of estrogen receptors, progesterone receptors, and Ki-67 antigen

2003

OBJECTIVE To enlighten the early response of endometrium to tamoxifen by assessing the expression of estrogen receptors, progesterone receptors, Ki-67, and the histological response in endometria from normal postmenopausal women treated for 21 days with tamoxifen. DESIGN A total of 40 women, scheduled to undergo vaginal hysterectomy because of uterine prolapse, were randomly assigned to the tamoxifen group (20 mg/day; 20 women) or the control group (20 women). Samples were obtained from the upper and the lower thirds of the uterine cavity. Standard immunohistochemical staining of estrogen and progesterone receptors and of Ki-67 was performed on frozen sections. Staining was assessed using s…

medicine.medical_specialtymedicine.drug_classAdministration OralEstrogen receptorEndometriumEndometriumInternal medicineProgesterone receptormedicineHumansEstrogen receptor betabusiness.industryAntibodies MonoclonalObstetrics and GynecologyMiddle AgedImmunohistochemistryPostmenopauseTamoxifenKi-67 AntigenEndocrinologymedicine.anatomical_structureReceptors EstrogenEstrogenFemaleSimple Endometrial HyperplasiaReceptors ProgesteronebusinessEstrogen receptor alphahormones hormone substitutes and hormone antagonistsTamoxifenmedicine.drugMenopause
researchProduct

Two-year prospective, randomized trial comparing an innovative twice-a-week progestin regimen with a continuous combined regimen as postmenopausal ho…

1999

Abstract Objective: To compare compliance, symptom control, bleeding patterns, endometrial response, and lipid changes in postmenopausal women treated with transdermal E 2 and a regimen of either intermittent or continuous dosing of progestin. Design: Randomized, prospective study. Setting: Menopausal Outpatient Clinic at an academic tertiary care hospital. Patient(s): One hundred women who had reached menopause naturally and had been amenorrheic for at least 1 year. Fifty women were randomly assigned to receive each regimen. Intervention(s): All patients received 50-μg E 2 patches and medroxyprogesterone acetate, either 5 mg twice per week or 2.5 mg daily. The bleeding pattern was register…

medicine.medical_specialtymedicine.drug_classMedroxyprogesteroneMedroxyprogesterone AcetateAdministration CutaneousEndometriumInternal medicinemedicineMedroxyprogesterone acetateOutpatient clinicHumansProspective StudiesProspective cohort studyAgedmedicine.diagnostic_testEstradiolProgesterone Congenersbusiness.industryEstrogen Replacement TherapyObstetrics and GynecologyMiddle Agedmedicine.diseaseLipidsSurgeryMenstruationMenopauseRegimenReproductive MedicinePatient ComplianceFemaleProgestinsbusinessProgestinmedicine.drugEndometrial biopsyFertility and sterility
researchProduct

Comparative effects of estradiol, raloxifene, and genistein on the uterus of ovariectomized mice.

2005

To explore the uterine effects of administration of compounds that exert their bone-sparing functions through estrogen receptors, we administered 17beta-E2, raloxifene, or genistein to ovariectomized mice and analyzed the uterus weight and histology 4 weeks after beginning the treatments. Results indicated that raloxifene and genistein have partial agonistic properties on the uterus in estrogen-depleted mice, and that genistein induced apoptosis and several atypias in the glandular epithelium of endometrium, as demonstrated in hematoxylin-eosin-stained histological sections.

medicine.medical_specialtymedicine.drug_classOvariectomyUterusGenisteinEstrogen receptorBiologyEndometriumchemistry.chemical_compoundMiceInternal medicinemedicineAnimalsRaloxifeneintegumentary systemEstradiolBody WeightUterusObstetrics and GynecologyAntiestrogenGenisteinMice Inbred C57BLmedicine.anatomical_structureEndocrinologyReproductive MedicinechemistryEstrogenRaloxifene HydrochlorideOvariectomized ratFemalemedicine.drugFertility and sterility
researchProduct

Prevention and treatment of cystitis during menopause: efficacy of a nutraceutical containing D-mannose, inulin, cranberry, bearberry, Olea europaea,…

2020

Aim of the study: To evaluate the efficacy of a nutraceutical compound containing Uticlin® (D-mannose, cranberry, bearberry, Olea europaea), inulin, Orthosiphon and Lactobacillus acidophilus, in preventing recurrent urinary tract infections (UTIs) in menopausal women. Material and methods: This was a prospective cohort study of menopausal women recruited with a history of recurrent UTIs in the previous twelve months and who intended to treat their bladder problem without the use of antibiotics and/or anti-inflammatories. Women were proposed the use of an oral nutraceutical compound. The drug was taken for ten days, every month. Women were assigned to two parallel cohorts: patients using (gr…

medicine.medical_specialtymedicine.drug_classVisual analogue scaleEndocrinology Diabetes and MetabolismUrinary systemCystitiAntibioticsmenopaused-mannoseGastroenterology03 medical and health sciences0302 clinical medicineLactobacillus acidophilusNutraceuticalInternal medicinemedicineutisProspective cohort studycystitisUrinary tract infection030219 obstetrics & reproductive medicineOrthosiphonbiologybusiness.industryRObstetrics and Gynecologybiology.organism_classificationmedicine.diseasenutraceutical.MenopauseMedicineNutraceuticalurinary tract infectionsbusinessMenopausal Review
researchProduct